Recombinant CTLA-4 (Ipilimumab Biosimilar) anticorps

N° du produit ABIN6964435

Cet anticorps anti-CTLA-4 (Ipilimumab Biosimilar) est un anticorps Human Monoclonal détectant CTLA-4 (Ipilimumab Biosimilar) dans FACS et ELISA. Adapté pour Humain.

Aperçu rapide pour Recombinant CTLA-4 (Ipilimumab Biosimilar) anticorps (ABIN6964435)

Antigène: CTLA-4 (Ipilimumab Biosimilar)

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Human

Clonalité: Monoclonal

Conjugué: Cet anticorp CTLA-4 (Ipilimumab Biosimilar) est non-conjugé

Application: Flow Cytometry (FACS), ELISA

Classe de qualité: Research Grade

Détail du produit anti-CTLA-4 (Ipilimumab Biosimilar) anticorps

Fonction: Anti-CTLA4 (ipilimumab biosimilar) mAb

Attributs du produit: BMS-734016, MDX-010, MDX-CTLA-4

Purification: Purified from cell culture supernatant by affinity chromatography

Isotype: IgG1

Information d'application

Indications d'application: ELISA 1:5000-10000, Flow Cyt 1:100

Commentaires:

Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Reconstitution: Reconstitute with deionized water

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Stock: -20 °C,-80 °C

Stockage commentaire: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Date de péremption: 12 months

Détails sur CTLA-4 (Ipilimumab Biosimilar)

Antigène: CTLA-4 (Ipilimumab Biosimilar)

Autre désignation: CTLA4 (Ipilimumab Biosimilar)

Classe de substances: Biosimilar

Sujet: Synonyms: CTLA4, CD152

UniProt: P16410